Key result
Camp Lejeune chemical exposure shows potential link to cutaneous scalp angiosarcoma in a veteran.
Why the study?
Angiosarcoma is an exceptionally rare malignancy, presenting an opportunity to evaluate the effects of chemical exposures at Camp Lejeune and their health implications.
Case Report (n=1)
This case highlights a potential association between historical chemical exposures at Camp Lejeune and the development of cutaneous angiosarcoma.
Answers are grounded in this paper and cite their sources.
Does not support practice change; leaves open whether Camp Lejeune exposures increase cutaneous angiosarcoma risk.
Angiosarcoma is an exceptionally rare malignancy that accounts for less than 1% of all sarcomas. This case describes a 90-year-old male veteran who presented with a hematoma from a traumatic head injury. This then progressed to an ulcerated bleeding lesion that measured 2.5 cm in diameter with pearly borders and granulation tissue. CT scan of the head and skin biopsy were consistent with the diagnosis of cutaneous angiosarcoma. The patient may have unique exposures from the military training site Camp Lejeune including tetrachloroethylene (PCE), trichloroethylene (TCE), trans-1,2-dichloroethylene, and vinyl chloride predisposing to angiosarcoma. The patient underwent palliative radiation without obvious complications. This case presents an opportunity for further evaluation and understanding of the effects of these exposures and the implications for the health of veterans and aging populations. Patient outcomes may be improved with earlier diagnosis and aggressive treatment.
No takes yet. Share an insight, caveat, or question.
Tessema et al. (2022) conducted a case report in Angiosarcoma (n=1). Palliative radiation therapy was evaluated. Chemical exposure at Camp Lejeune was potentially linked to the development of cutaneous angiosarcoma of the scalp in a 90-year-old male veteran.
Synapse has enriched 10 related papers. Consider them for comparative context: